Amgen Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) inched 0.30% higher to $288.16 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.39% to 3,949.94 and Dow Jones Industrial Average falling 0.13% to 33,700.28. Amgen Inc. closed $8.51 short of its 52-week high ($296.67), which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.51% to $175.97, Roche Holding AG Part. Cert. rose 0.54% to $318.30, and Pfizer Inc. (PFE) fell 0.10% to $48.18. Trading volume (2.8 M) remained 95,643 below its 50-day average volume of 2.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2022.
(END) Dow Jones Newswires
November 21, 2022 16:36 ET (21:36 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.